EMA — authorised 21 January 2013
- Status: approved
EMA authorised Tresiba on 21 January 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 21 January 2013.
Novo Nordisk is the originator. The local marketing authorisation holder may differ — check the official source linked above.